Concord Medical Services Holdings (CCM) Cash & Equivalents (2009 - 2025)

Concord Medical Services Holdings (CCM) has 17 years of Cash & Equivalents data on file, last reported at $42.0 million in Q4 2025.

• Quarterly Cash & Equivalents rose 39.48% year-over-year to $42.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $42.0 million (up 39.48% YoY) and the FY2025 annual result came in at $42.6 million, up 31.16% from the prior year.
• Cash & Equivalents retreated to $42.0 million in Q4 2025, from $24.8 billion in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $38.2 billion in Q2 2021 to a low of $8.1 million in Q4 2023.
• A 5-year average of $9.0 billion and a median of $38.4 million in 2023 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2021 — Cash & Equivalents tumbled 99.95% — and 2024, when it surged 45702.87%.
• Tracing CCM's Cash & Equivalents over 5 years: stood at $24.9 million in 2021, then slipped by 9.86% to $22.4 million in 2022, then slumped by 63.96% to $8.1 million in 2023, then surged by 272.79% to $30.1 million in 2024, then soared by 39.48% to $42.0 million in 2025.
• The last three Cash & Equivalents figures came in at $42.0 million (Q4 2025), $24.8 billion (Q2 2025), and $30.1 million (Q4 2024), per Business Quant data.